Xenetic Biosciences Inc (XBIO)
3.899
+0.06
(+1.62%)
USD |
NASDAQ |
May 24, 16:00
3.83
-0.07
(-1.76%)
After-Hours: 20:00
Xenetic Biosciences Enterprise Value: -1.815M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -1.815M |
| May 23, 2024 | -1.911M |
| May 22, 2024 | -1.721M |
| May 21, 2024 | -2.090M |
| May 20, 2024 | -2.014M |
| May 17, 2024 | -2.263M |
| May 16, 2024 | -2.352M |
| May 15, 2024 | -1.728M |
| May 14, 2024 | -1.967M |
| May 13, 2024 | -1.782M |
| May 10, 2024 | -1.820M |
| May 09, 2024 | -1.595M |
| May 08, 2024 | -1.775M |
| May 07, 2024 | -1.890M |
| May 06, 2024 | -1.721M |
| May 03, 2024 | -1.243M |
| May 02, 2024 | -1.813M |
| May 01, 2024 | -1.451M |
| April 30, 2024 | -1.197M |
| April 29, 2024 | -1.659M |
| April 26, 2024 | -1.521M |
| April 25, 2024 | -2.004M |
| April 24, 2024 | -1.890M |
| April 23, 2024 | -1.890M |
| April 22, 2024 | -2.029M |
| Date | Value |
|---|---|
| April 19, 2024 | -1.351M |
| April 18, 2024 | -1.443M |
| April 17, 2024 | -1.875M |
| April 16, 2024 | -1.636M |
| April 15, 2024 | -1.443M |
| April 12, 2024 | -1.151M |
| April 11, 2024 | -0.9978M |
| April 10, 2024 | -0.6023M |
| April 09, 2024 | -0.5498M |
| April 08, 2024 | -0.6576M |
| April 05, 2024 | -0.6885M |
| April 04, 2024 | -1.043M |
| April 03, 2024 | -0.7039M |
| April 02, 2024 | -1.058M |
| April 01, 2024 | -1.351M |
| March 31, 2024 | -2.014M |
| March 28, 2024 | -3.173M |
| March 27, 2024 | -2.849M |
| March 26, 2024 | -3.096M |
| March 25, 2024 | -2.896M |
| March 22, 2024 | -3.034M |
| March 21, 2024 | -2.896M |
| March 20, 2024 | -2.510M |
| March 19, 2024 | -2.433M |
| March 18, 2024 | -2.433M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.750M
Minimum
Dec 28 2022
42.12M
Maximum
Jul 29 2021
-0.4628M
Average
-2.828M
Median
May 26 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 755.01M |
| Electromed Inc | 132.41M |
| Xtant Medical Holdings Inc | 120.35M |
| Asensus Surgical Inc | 57.64M |
| Myomo Inc | 99.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.195M |
| Revenue (Quarterly) | 0.5108M |
| Total Expenses (Quarterly) | 1.779M |
| EPS Diluted (Quarterly) | -0.78 |
| Profit Margin (Quarterly) | -234.0% |
| Earnings Yield | -75.15% |
| Normalized Earnings Yield | -75.15 |